Dimensional Fund Advisors LP Vir Biotechnology, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 3,007,955 shares of VIR stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,007,955

Previous 2,684,415 12.05%

Holding current value

$13.1 Million

Previous $17.4 Million 12.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$4.5 - $6.48 $1.46 Million - $2.1 Million	323,540 Added 12.05%	3,007,955 $15.2 Million
Q1 2025 May 13, 2025	BUY	$6.48 - $12.48 $4.98 Million - $9.6 Million	768,950 Added 40.14%	2,684,415 $17.4 Million
Q4 2024 Feb 13, 2025	BUY	$6.74 - $10.17 $4.74 Million - $7.15 Million	703,360 Added 58.03%	1,915,465 $14.1 Million
Q3 2024 Nov 07, 2024	BUY	$7.26 - $10.7 $4.17 Million - $6.15 Million	574,619 Added 90.14%	1,212,105 $9.08 Million
Q2 2024 Aug 09, 2024	BUY	$7.63 - $12.66 $445,286 - $738,837	58,360 Added 10.08%	637,486 $5.67 Million
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $952,940 - $1.32 Million	110,807 Added 23.66%	579,126 $5.87 Million
Q4 2023 Feb 07, 2024	SELL	$7.76 - $10.29 $2.01 Million - $2.67 Million	-259,296 Reduced 35.64%	468,319 $4.71 Million
Q3 2023 Nov 09, 2023	SELL	$9.14 - $24.62 $2.7 Million - $7.27 Million	-295,124 Reduced 28.86%	727,615 $6.82 Million
Q2 2023 Aug 09, 2023	BUY	$23.2 - $27.29 $22.7 Million - $26.7 Million	977,639 Added 2167.71%	1,022,739 $25.1 Million
Q3 2022 Nov 10, 2022	SELL	$18.26 - $31.1 $1.32 Million - $2.25 Million	-72,279 Reduced 61.58%	45,100 $870,000
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $9.44 Million - $13.2 Million	-494,957 Reduced 80.83%	117,379 $2.99 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $6.18 Million - $11.7 Million	291,785 Added 91.03%	612,336 $15.7 Million
Q4 2021 Feb 09, 2022	BUY	$30.97 - $54.03 $8.33 Million - $14.5 Million	269,069 Added 522.65%	320,551 $13.4 Million
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $481,375 - $752,270	13,793 Added 36.6%	51,482 $2.24 Million
Q2 2021 Aug 12, 2021	SELL	$38.75 - $51.0 $402,263 - $529,431	-10,381 Reduced 21.6%	37,689 $1.78 Million
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $1.01 Million - $3.17 Million	38,200 Added 387.03%	48,070 $2.47 Million
Q4 2020 Feb 25, 2021	BUY	$25.51 - $43.38 $251,783 - $428,160	9,870 New	9,870 $264,000

Others Institutions Holding VIR

# of Institutions

242

Shares Held

109M

Call Options Held

342K

Put Options Held

150K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $578M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Vir Biotechnology, Inc. Transaction History